INTRODUCTION
Acute otitis media (AOM) is one of the most common diseases in children and the most frequent reason for antimicrobial prescriptions in highresource countries. It is currently acknowledged that AOM is a bacterial complication of viral upper respiratory tract infection (URI); however, viruses alone can cause AOM. The high incidence of AOM results from the exceedingly high burden of viral URIs. Approximately 35% of URI episodes are complicated by AOM, occurring mainly within the first week of URI onset [1, 2] . In the past 15 years, medical progress has been made toward the prevention of AOM, which has led to the reduction of otitis visit rates to the physicians and in antibiotic prescriptions [3,4 & ]. This was attributed to the widespread use of bacterial and viral vaccines, and the introduction of the observation option in patients with mild to moderate AOM without initial antibiotic treatment [5] . Bacterial vaccine against Streptococcus pneumoniae, the leading AOM pathogenic bacteria, was first introduced in 2000. Since then, pneumococcal conjugate vaccines have been implemented into many national immunization programs worldwide [4 & ]. Concurrently, routine influenza vaccination in children has been recommended in the past decade. Influenza vaccines have been shown to effectively prevent seasonal influenza and influenza-associated AOM, and early treatment in the course of influenza with antiviral therapy also reduced AOM complication rates [6] [7] [8] [9] . In the present article, we review the current literature related to the importance of respiratory viruses in AOM, and discuss how the increased knowledge in this area may lead to better prevention strategies for the further reduction of AOM burden.
RESPIRATORY VIRUSES
Viral respiratory infections are the most common diseases in children around the world. Although some of the recently discovered respiratory viruses (e.g. coronaviruses of the severe acute respiratory syndrome and the Middle East respiratory syndrome) have gained a lot of publicity [10] , common respiratory viruses still have remarkably more impact on human health worldwide. Viral URI is usually mild and self-limiting, but the universality of the disease causes remarkable economic impact and burden [11] . In addition, URI is often complicated by bacterial infections such as AOM, acute bacterial sinusitis or pneumonia requiring antibiotic treatment [12] . In high-resource countries, public concern over viral epidemics can greatly affect and lead to increased economic costs. For example, the 2009 influenza A/H1N1 pandemic resulted in an increase in parent-initiated visits as a result of respiratory symptoms for healthy infants in their first year of life [13] , probably because of increased parental anxiety. Yet, the influenza pandemic had no impact on the overall viral epidemiology of respiratory infections in these infants.
Multiple respiratory viruses are of hundreds of different serotypes; these viruses can cause the common cold, or URI. The most common respiratory viruses causing URI in children are:
-Adenoviruses -Coronaviruses -Enteroviruses -Human bocavirus type 1 -Human metapneumovirus -Influenza viruses -Parainfluenza viruses -Respiratory syncytial virus -Rhinoviruses
Rhinoviruses and coronaviruses (229E, OC43 and NL63) are the most common causes of URI. Other virus groups that also cause URI may have distinct features, for example, respiratory syncytial virus (RSV) is the leading cause for severe bronchiolitis requiring hospitalization among neonates and infants, influenza viruses cause yearly epidemics with potentially severe respiratory symptoms and complications, and parainfluenza viruses are commonly associated with acute laryngitis. Relatively new respiratory viruses such as human bocaviruses and metapneumoviruses have also been shown to cause URI and AOM in children [14-16,17 & ]. Although human bocavirus type 1 causes primarily respiratory infections, virus shedding can persist in the nasopharynx for a long period; therefore, the overall significance of this virus in respiratory infections is still unclear [15,17 & ].
PATHOGENESIS OF VIRUS-INDUCED ACUTE OTITIS MEDIA
AOM usually occurs concurrently or just after URI; more than 90% of children with AOM have concurrent URI symptoms. The three most common bacterial otopathogens, S. pneumoniae, nontypeable Haemophilus influenzae and Moraxella catarrhalis, colonize the infant's nasopharynx from an early age, and do not infect the respiratory tract or cause symptoms until viral URI (nasopharyngitis) occurs, causing changes in the nasopharyngeal milieu. The coexistence of bacterial otopathogens and the complex interactions between bacteria and respiratory viruses have an effect on the URI course and eventually on AOM outcome [18,19 && ,20]. Earlier reports from experimental animal models, in-vitro studies, studies of adult volunteers infected with respiratory viruses and studies of children with URI have led to the understanding of essential steps in the pathogenesis of AOM development after URI ( Fig. 1 ). Respiratory viruses cause inflammation of the nasopharynx and the Eustachian tube, generating host immune and inflammatory responses, including the generation of cytokines, chemokines and inflammatory mediators. Viral infections also increase nasopharyngeal colonization and adherence of bacteria to epithelial cells. The chemical and immunological properties of the secreted substances change the mucous property and diminish the normal mucociliary clearance of the nasopharyngeal and tympanomastoid mucosal cells. Eustachian tube dysfunction/obstruction and negative middle ear pressure then occur, facilitating the entrance of both colonized bacteria and respiratory viruses from the nasopharynx into the middle ear cavity. The middle ear inflammation follows, leading to
KEY POINTS
Acute otitis media occurs as a complication of symptomatic viral upper respiratory tract infection, even in the absence of nasopharyngeal bacterial colonization.
Bacterial otopathogens and respiratory viruses interact and play important roles in acute otitis media development. 
VIRUSES AS ACUTE OTITIS MEDIA PATHOGENS
Although AOM is often bacterial or viral-bacterial coinfection, there is evidence that respiratory virus alone, without coinfecting bacteria, can cause AOM. Experimental studies in adults and in chinchillas have shown that induced virus infection can lead to the development of AOM. Revai et al. [22] reported that 10% of children with AOM had no detectable bacterial pathogens colonized in the nasopharynx, suggesting that these are cases of viral AOM. Ruohola et al. [19 && ] recently reported an increased risk of AOM in patients infected with RSV, without colonized bacteria. Further evidence of viral AOM [23] [24] [25] has emerged from viruses or viral nucleic acids being detected from the middle ear fluid of children with AOM in the absence of bacteria.
Although any virus that causes URI can lead to AOM, it has been suggested that certain viruses are more likely to cause AOM than others, for example, more 'ototropic'. Among the common respiratory viruses, RSV has always been identified as an AOMassociated virus, while results on AOM associated with other viruses have not been consistent. In a prospective study of 294 young children [1, 17 & ], we reported increased AOM risks with URI associated with RSV, coronaviruses, adenoviruses and human bocavirus. Because of the high prevalence of rhinovirus URI in general, even without an increased rate of AOM development after URI, rhinoviruses are also considered common AOM-associated viruses. In a study by Wiertsema et al. [23] , rhinoviruses, human bocaviruses, parainfluenza viruses, adenoviruses and RSV were detected significantly more often in the nasopharynx of children with a history of recurrent AOM, compared with healthy children controls. In a recent report [26] , results of respiratory virus testing of more than 96 000 specimens from children during 9 respiratory seasons showed that detection of RSV, human metapneumovirus and influenza was temporally associated with increased diagnoses of AOM.
With the widespread use of molecular diagnostics, respiratory viruses have been detected in up to 50% of asymptomatic young children. Our most recent study [27 && ] described 403 asymptomatic viral infections in 237 infants. While the overall rate of AOM following URI in the first year of life was 27%, no AOM had occurred following asymptomatic viral infections. This interesting finding highlights the fact that AOM development following URI requires an inflammation severe enough to initiate the expression of URI symptoms, which is also likely to be associated with Eustachian tube dysfunction. Risk factors other than severity of viral infections are also likely to play a role in AOM development.
ACUTE OTITIS MEDIA RISK FACTORS
Why only one in three young children develops AOM after URI and the other two do not may depend on numerous factors. It is clear that AOM is a multifactorial disease; important risk factors include type and dose of the pathogen(s), environmental factors, such as feeding type, cigarette smoke exposure and day care attendance, and the individual genetic risks. Recurrent AOM or otitis proneness is associated with familial tendency, specific ethnic populations and specific single nucleotide polymorphisms of cytokine/chemokine genes [28] [29] [30] [31] [32] . Individuals may have different genetic susceptibilities to respiratory infections and different immune responses to infections, which have an effect on the susceptibility for the development of AOM complication. The large variety of different cytokines, chemokines and the possible polymorphic genes, however, makes this entity difficult and complex to study. Research in this field has just scratched the surface. The most important risk factors for AOM development are the colonized bacterial otopathogens in the nasopharynx, the presence of respiratory viruses and their complex interactions [33] . In children with URI, those who are colonized with otopathogens are more likely to have concomitant AOM than those who are not [19 && ]; AOM risk differs by the specific viruses and bacteria involved. Recent studies have aimed to determine the 'threshold' of bacterial and viral loads that are sufficient enough to cause AOM; the results so far have been conflicting. In a study of Australian Indigenous children with AOM [34] , nasopharyngeal nontypeable H. influenzae load was significantly elevated in the presence of enterovirus and coronavirus, and loads of M. catarrhalis and nontypeable H. influenzae were higher when multiple viruses were detected. At no point were the individual bacterial loads lower in the presence of a respiratory virus. Pettigrew et al. [20] demonstrated that children with high RSV loads in nasopharyngeal samples had an increased AOM risk, and AOM risk was independently associated with high RSV viral load with S. pneumonia and nontypeable H. influenzae. The risk was higher for the presence of bocavirus and nontypeable H. influenzae together. In a recent study [27 && ], higher viral loads were found in nasopharyngeal specimens from infants with symptomatic URI associated with RSV, rhinoviruses, human metapneumovirus, adenovirus, parainfluenza viruses 1 and 3, coronaviruses, enteroviruses and bocavirus, compared with viral loads in asymptomatic viral infections. Interestingly, viral loads did not differ between viral URI with and without AOM. These findings imply the important influence of other multiple risk factors for AOM development.
CLINICAL IMPLICATIONS
The knowledge on the importance of viruses in AOM has clinical implications, specifically on the treatment and prevention. Because respiratory viruses usually coinfect with bacteria in the middle ear, AOM is often not a 'pure bacterial disease'. Nevertheless, in studies for which AOM diagnostic criteria were stringent, bacterial pathogens were isolated from the middle ear fluid in a high proportion of the patients (e.g. 80-90%), mostly with the three otopathogens singly or in combination. In children with AOM, respiratory viruses have been identified from the middle ear fluid in 20-70% of patients using conventional and molecular diagnostic methods. At present, the antimicrobial treatment available for AOM includes only antibiotics; as viral infection is generally self-limited, no antiviral drug is recommended. Some cases of AOM may not require antibiotic because AOM may be a 'pure viral infection', or because the middle ear exudate containing bacteria (e.g. pus) may drain via the Eustachian tubes once the function of the tubes return to normal (a few to several days). On the basis of recent studies, including clinical trials for which stringent criteria for AOM diagnosis were applied [35, 36] , the American Academy of Pediatrics has updated the clinical practice guideline on diagnosis and treatment of AOM in 2013 [5] . Initial antibiotic therapy is now recommended only in infants and children with severe symptoms of AOM or if they present with otorrhea, presumably with rupture of the tympanic membrane. Children with nonsevere symptoms, including those younger than 2 years of age with unilateral AOM, may be observed without antibiotic initially.
For prevention purposes, the overall goal is to reduce or prevent nasopharyngeal colonization of bacterial otopathogens, and prevent young children from having viral URI. While the importance of reducing environmental risks cannot be overemphasized, the use of bacterial and viral vaccines will likely make a significant impact. Of the three otopathogens, only vaccines against S. pneumoniae are currently available. Prelicensure controlled studies of pneumococcal conjugate vaccine for seven serotypes (PCV7) have shown 6-8% reduction of AOM in vaccinated children, compared with that in controls. The reduction of AOM in the 2000s may have been the result of PCV7 and influenza vaccine use, and other factors such as parents' education toward reducing AOM risk factors and physicians' efforts to minimize AOM overdiagnosis. The licensure of the current pneumococcal vaccine (PCV13) in 2010 in the United States, with a broader coverage for six additional serotypes, has further reduced otitis media-related healthcare use [4 & ].
Prevention of viral URI is complicated because of the variety of numerous respiratory virus types that are associated with URI. Nevertheless, progress has been made through the use of influenza vaccines, the only available respiratory virus vaccines to date. Since early 1990s, investigators [6, 7] have shown that trivalent, inactivated influenza vaccines and, later, live-attenuated influenza vaccine have effectively prevented AOM during influenza seasons. The vaccines work through preventing influenza illness and influenza-associated AOM. Therefore, the efficacy/effectiveness in AOM prevention varies from year to year, depending on the efficacy of the vaccine against influenza illnesses, which ties to the level of influenza activity in the community and how well matched the vaccines are for the circulating strains. The higher the influenza activity in the season, the higher the likelihood is that the 'well-matched' vaccines will be more effective in preventing influenza and influenza-associated AOM when compared with controls. In addition, there have been studies on the prevention of AOM by early treatment of influenza in children [9] , which showed that treatment with oral oseltamivir significantly reduced new AOM in young children with laboratory-confirmed influenza infection. Prevention of AOM through the use of respiratory viral vaccines has a potential to be more effective with the availability of vaccines for more common AOM-associated viruses such as RSV. Despite decades of RSV vaccine research, however, no RSV vaccine has been developed for phase III clinical trials to date. Any future progress made toward vaccination against common respiratory viruses will have an impact on reducing the burden of AOM.
CONCLUSION
While bacterial otopathogens colonize the nasopharynx from early age, symptomatic viral URI is needed to initiate the development of AOM. In 5-10% of patients, AOM occurs in the absence of detectable colonizing pathogenic bacteria. A variety of common respiratory viruses play an important role in the pathogenesis and interact with bacteria during AOM. Successful prevention of the disease will rely on prevention of nasopharyngeal bacterial colonization, as well as reduction of viral URI incidence.
